In addition, the IL-23/Th17/IL-17 pathway is one of the most important inflammatory processes in psoriasis, and its therapeutic blockade with biological agents is highly effective in the treatment of moderate to severe psoriasis [29]. The gene discussed is IL37; the disease is psoriasis.